IntegriChain is a channel management cloud used by life sciences suppliers, including nine of the top 10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems.
Missing: IntegriChain's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: IntegriChain's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing IntegriChain
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
IntegriChain is included in 1 Expert Collection, including Digital Health.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest IntegriChain News
Nov 29, 2022
News provided by Share this article Share this article PHILADELPHIA, Nov. 29, 2022 /PRNewswire/ -- IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, today announced that pharmaceutical distribution expert and Vice President of Industry Solutions David Weiss will speak at Informa's Trade & Channel Strategies conference. In addition, Bill Roth , General Manager and Managing Partner of Blue Fin Group, will be the keynote speaker for the event. IntegriChain is a sponsor of the hybrid conference, which runs December 12 through 14 in Philadelphia. Details of the highlighted sessions on Monday, December 12, during the conference are as follows. Keynote: Current and Future Trends Impacting Trade and Distribution Bill Roth 8:45 am ET Roth will deliver an overview of the manufacturer landscape; medical and pharmacy benefit products; key therapeutics classes including oncology, immunology, and neurology; and trends shaping biosimilars, specialty generics, orphan/rare and cell and gene therapies. State of the Channel 2022 Dave Weiss 10:45 am ET Weiss will offer an overview of the current state of the channel performance related to inventory, service level, and other key metrics using the IntegriChain proprietary benchmark database. He'll explore the latest trends in innovative channel designs and offer observations and learnings from recent specialty lite launches. About ICyte Data Solutions IntegriChain offers a full suite of channel data products, including: Channel Data Aggregation: Aggregation of all channel and distribution datasets including ExFactory Sales, Distributor Inventories, Demand, and Returns to deliver the highest quality master data, including industry-leading data science and enrichment algorithms to deliver end-to-end views of product distribution. Inventory Analytics: Manufacturers have few existing measures of the inventory held in retail stores, distribution centers, and third-party returns processors. IntegriChain Inventory Analytics reports 100% of inventory in the retail channel, even in pharmacy stores and distribution centers that do not report their inventories. Distribution Contract Management: Distribution Contract Management is a single, auditable application for managing all aspects of trade partner agreements. Configurable trade partner scorecard functionality features payment adjudication, custom pay-for-performance metrics, payment roll forward, and top- and bottom-line functionality adjustments. Channel Data Consulting Services: Based on IntegriChain pioneering the field of channel data aggregation, stewardship, and advanced analytics, the Channel Insights and Optimization practice delivers Market Demand Analysis, Class of Trade, Downstream Inventory Analytics, Returns Forecasting, and Revenue Analytics consulting services to Pharma manufacturers of all types and sizes. About IntegriChain IntegriChain delivers pharma's only comprehensive technology, data, consulting, and outsourcing platform for market access departments. We provide the strategy and operational execution for data-driven product commercialization and market access. More than 400 manufacturers rely on our consulting expertise and ICyte Platform to orchestrate their prescription management, patient data management, inventory and demand visibility, enterprise GTN technology, and platform insights. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support commercialization and access in the era of specialty and precision medicine. With ICyte, pharmaceutical innovators can achieve strategic commercial advantage and better commercial outcomes by digitalizing daily and recurring business activities and by orchestrating those activities with increasingly diagnostic and/or predictive analytics. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. We are headquartered in Philadelphia, PA, with offices in Ambler, PA; New York, NY, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com , or follow on Twitter @ IntegriChain and on LinkedIn . About Blue Fin Group, an IntegriChain Company Blue Fin Group develops strategies to optimize patient access, commercialization, and gross-to-net to support life sciences manufacturers throughout the product life cycle. Blue Fin Group is a full-service management consulting firm delivering research, strategy, and implementation to help manufacturers align all the elements of marketing, market access, field sales, pharmacy and distribution, and patient services as a seamless commercial strategy that helps optimize patient outcomes. Blue Fin Group has served more than 300 manufacturers–primarily those commercializing their first asset or large global firms with products that span cell and gene therapies, orphan/rare, specialty, primary care, vaccines, biosimilars, and generics. For additional information, visit https://consultbfg.com/ or follow on Twitter bluefingroup and LinkedIn . Contact SOURCE IntegriChain
IntegriChain Web Traffic
IntegriChain Frequently Asked Questions (FAQ)
When was IntegriChain founded?
IntegriChain was founded in 2007.
Where is IntegriChain's headquarters?
IntegriChain's headquarters is located at 8 Penn Center, 1628 JFK Boulevard, Philadelphia.
What is IntegriChain's latest funding round?
IntegriChain's latest funding round is Acq - Fin.
How much did IntegriChain raise?
IntegriChain raised a total of $8M.
Who are the investors of IntegriChain?
Investors of IntegriChain include Accel-KKR, SaaS Capital, Activate Venture Partners, Cross Atlantic Partners, NJTC Venture Fund and 3 more.
Who are IntegriChain's competitors?
Competitors of IntegriChain include Pharmaca Integrative Pharmacy, RxStrategies, PharMEDium Healthcare Holdings, Centice, Remedi Seniorcare and 7 more.
Compare IntegriChain to Competitors
Apex Pharmacies Ltd. was founded in 2004. The Apex business plan involves bringing together experienced pharmacy operators with financial professionals and ensuring access to capital. Apex will acquire highly sought after pharmacy targets in Western Canada at a pace that aims to allow integration of these acquisitions into the overall Apex chain, while maintaining strong bottom line performance. www.apexpharmacies.com .
Remedi SeniorCare delivers comprehensive pharmacy services, pharmacy consulting, and data management services to nursing homes, assisted living, and continuing care retirement communities. The business is committed to helping these organizations achieve outstanding care, financial strength, and medication safety. Remedi combines their culture of caring with real-world pharmacy services and best-in-class technology to give organizations more time and resources and help them focus on caring for their residents.
RxStrategies is a provider of discounted prescription medicines.
SFJ Pharmaceuticals is a Specialty Pharma Company deploying a new business model for the clinical development and registration of pharmaceutical products. SFJ Pharmaceuticals provides a financially advantageous and creative alternative approach to partnering. The comapny can provide the strategic financing, clinical development and regulatory resources for the clinical development and approval of products. SFJ Pharmaceuticals is staffed with a seasoned team of professionals, with extensive experience in the clinical development and regulatory approval of pharmaceutical products.
ForHealth Technologies is a manufacturer of pharmacy-based systems that aim to automate the preparation of sterile, intravenous medications.
Ro is a patient-driven telehealth company that puts patients in control of their health. The company builds technology to make healthcare accessible, affordable, and enjoyable. Ro powers three digital health clinics: Roman for men’s health, Rory for women’s health, and Zero for fighting smoking cessation. It also operates Ro Pharmacy, a simple and affordable online pharmacy where every generic medication is $5 per month. Ro’s nationwide network of physicians and pharmacies provides a personalized, end-to-end healthcare experience from online treatment to the delivery of medication and ongoing care. The company was founded in 2017 and is based in New York, New York.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.